The Stroke Warning Information and Faster Treatment Study (SWIFT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00415389|
Recruitment Status : Terminated (Approval lapse)
First Posted : December 22, 2006
Last Update Posted : February 18, 2013
|Condition or disease||Intervention/treatment||Phase|
|Stroke||Behavioral: interactive educational program Behavioral: usual medical care||Phase 2|
Rapid diagnosis and treatment of acute ischemic stroke is critical to reduce disability and death caused by stroke. While recombinant tissue plasminogen activator, or rt-PA, is the only approved treatment for acute ischemic stroke, less than 2-3 percent of individuals with stroke actually receive treatment. The inability to capture acute ischemic stroke cases within 3 hours of symptom onset is one critical factor. Populations at highest risk for stroke are significantly undereducated about the need for rapid, intervention upon onset of stroke symptoms. This is especially true among vulnerable populations including African Americans, Hispanics, and the poor.
The purpose of this study is to evaluate the effectiveness of a 2-session, culturally-sensitive, interactive stroke educational program compared to standard educational materials and usual care. In this study, the scientists will determine if the interactive program increases knowledge about stroke, and results in earlier arrival to the emergency room in the case of stroke.
The study will enroll 1400 individuals who have had a stroke or transient ischemic attack (TIA). Participants will be randomized to receive usual medical care——which includes standard educational information on stroke, stroke warning signs and risk factors——or usual medical care plus a 2-session interactive stroke educational program. All participants will be administered pre and post (30 days and 1 year) intervention stroke knowledge/behavior surveys. In additional, participants will be contacted every 12 months to check health status and document new stroke events associated with emergency room arrival time.
The SWIFT study is part of the Specialized Program for Translational Research in Acute Stroke (SPOTRIAS), which seeks to understand why certain people may be at increased risk for stroke. The goal of the study is to increase stroke knowledge, change behavior, and improve emergency room arrival times upon onset of stroke symptoms.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1635 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||The Stroke Warning Information and Faster Treatment Study (SWIFT)|
|Study Start Date :||February 2005|
|Actual Primary Completion Date :||October 2012|
|Actual Study Completion Date :||October 2012|
Active Comparator: 1
interactive educational program
Behavioral: interactive educational program
2-session interactive stroke educational program
Active Comparator: 2
usual medical care
Behavioral: usual medical care
standard educational materials and usual care
- Surveillance methodologies will measure arrival times of acute strokes from stroke symptoms onset to ER among participants for the length of the study, as well as increase in stroke knowledge at one month and one year post stroke event. [ Time Frame: at one month and one year post stroke event ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00415389
|United States, New York|
|Neurological Institute, 710 W 168th Street, 6th Floor, Room 640|
|New York, New York, United States, 10032|
|Principal Investigator:||Bernadette Boden-Albala, DrPH||Columbia University|